Your browser doesn't support javascript.
loading
Cost-effectiveness and budget impact of decentralising childhood tuberculosis diagnosis in six high tuberculosis incidence countries: a mathematical modelling study.
d'Elbée, Marc; Harker, Martin; Mafirakureva, Nyashadzaishe; Nanfuka, Mastula; Huyen Ton Nu Nguyet, Minh; Taguebue, Jean-Voisin; Moh, Raoul; Khosa, Celso; Mustapha, Ayeshatu; Mwanga-Amumpere, Juliet; Borand, Laurence; Nolna, Sylvie Kwedi; Komena, Eric; Cumbe, Saniata; Mugisha, Jacob; Natukunda, Naome; Mao, Tan Eang; Wittwer, Jérôme; Bénard, Antoine; Bernard, Tanguy; Sohn, Hojoon; Bonnet, Maryline; Wobudeya, Eric; Marcy, Olivier; Dodd, Peter J.
Afiliación
  • d'Elbée M; University of Bordeaux, National Institute for Health and Medical Research (Inserm) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux, France.
  • Harker M; Ceped UMR 196, Université Paris Cité, Research Institute for Sustainable Development (IRD), Inserm, Paris, France.
  • Mafirakureva N; TB Modelling Group, TB Centre, and Global Centre for Health Economics, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Nanfuka M; School of Health & Related Research, University of Sheffield, Sheffield, United Kingdom.
  • Huyen Ton Nu Nguyet M; MU-JHU Care Ltd, MUJHU Research Collaboration, Kampala, Uganda.
  • Taguebue JV; University of Bordeaux, National Institute for Health and Medical Research (Inserm) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux, France.
  • Moh R; Mother and Child Center, Chantal Biya Foundation, Yaoundé, Cameroon.
  • Khosa C; Teaching Unit of Dermatology and Infectiology, UFR of Medical Sciences, Félix-Houphouët Boigny University, Abidjan, Côte d'Ivoire.
  • Mustapha A; Programme PAC-CI, CHU de Treichville, Abidjan, Côte d'Ivoire.
  • Mwanga-Amumpere J; Instituto Nacional de Saúde, Marracuene, Mozambique.
  • Borand L; Ola During Children's Hospital, Freetown, Sierra Leone.
  • Nolna SK; Epicentre Mbarara Research Centre, Mbarara, Uganda.
  • Komena E; Epidemiology and Public Health Unit, Clinical Research Group, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
  • Cumbe S; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Mugisha J; TransVIHMI, University of Montpellier, IRD /INSERM, Montpellier, France.
  • Natukunda N; Programme PAC-CI, CHU de Treichville, Abidjan, Côte d'Ivoire.
  • Mao TE; Instituto Nacional de Saúde, Marracuene, Mozambique.
  • Wittwer J; SOLTHIS, Sierra Leone.
  • Bénard A; Epicentre Mbarara Research Centre, Mbarara, Uganda.
  • Bernard T; Ministry of Health, Cambodia.
  • Sohn H; University of Bordeaux, National Institute for Health and Medical Research UMR 1219, Bordeaux, France.
  • Bonnet M; CHU Bordeaux, Service d'information Médicale, USMR & CIC-EC 14-01, Bordeaux, France.
  • Wobudeya E; Bordeaux School of Economics, Bordeaux, France.
  • Marcy O; Seoul National University College of Medicine, Seoul, South Korea.
  • Dodd PJ; TransVIHMI, University of Montpellier, IRD /INSERM, Montpellier, France.
EClinicalMedicine ; 70: 102528, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38685930
ABSTRACT

Background:

The burden of childhood tuberculosis remains high globally, largely due to under-diagnosis. Decentralising childhood tuberculosis diagnosis services to lower health system levels could improve case detection, but there is little empirically based evidence on cost-effectiveness or budget impact.

Methods:

In this mathematical modelling study, we assessed the cost-effectiveness and budget impact of decentralising a comprehensive diagnosis package for childhood tuberculosis to district hospitals (DH-focused) or primary health centres (PHC-focused) compared to standard of care (SOC). The project was conducted in Cambodia, Cameroon, Côte d'Ivoire, Mozambique, Sierra Leone, and Uganda between August 1st, 2018 and September 30th, 2021. A mathematical model was developed to assess the health and economic outcomes of the intervention from a health system perspective. Estimated outcomes were tuberculosis cases, deaths, disability-adjusted life years (DALYs) and incremental cost-effectiveness ratios (ICERs). We also calculated the budget impact of nationwide implementation. The TB-Speed Decentralization study is registered with ClinicalTrials.gov, NCT04038632.

Findings:

For the DH-focused strategy versus SOC, ICERs ranged between $263 (Cambodia) and $342 (Côte d'Ivoire) per DALY averted. For the PHC-focused strategy versus SOC, ICERs ranged between $477 (Cambodia) and $599 (Côte d'Ivoire) per DALY averted. Results were sensitive to TB prevalence and the discount rate used. The additional costs of implementing the DH-focused strategy ranged between $12.8 M (range 10.8-16.4) (Cambodia) and $50.4 M (36.5-74.4) (Mozambique), and between $13.9 M (12.6-15.6) (Sierra Leone) and $134.6 M (127.1-143.0) (Uganda) for the PHC-focused strategy.

Interpretation:

The DH-focused strategy may be cost-effective in some countries, depending on the cost-effectiveness threshold used for policy making. Either intervention would require substantial early investment.

Funding:

Unitaid.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: EClinicalMedicine Año: 2024 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: EClinicalMedicine Año: 2024 Tipo del documento: Article País de afiliación: Francia